Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms

• Status: Completed
• Trial end date: 2011-12-14
• Target enrollment: 0
• Participant gender: Male

Summary

Clinical study to examine the safety, tolerability and efficacy of long-term combination therapy of tamsulosin and solifenacin in the treatment of males with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) with a substantial storage component.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma Europe B.V.
• Treatments: Solifenacin Succinate; Tamsulosin

Criteria

Inclusion Criteria:

• Completion of 12 weeks double-blind treatment in Study 905-CL-055

Exclusion Criteria:

• Any significant PVR volume (>150 mL)